Press release
Antioxidants May Aid in the Treatment of Tardive Dyskinesia
Memphis, TN (May 9, 2019) – Today, The Primary Care Companion for CNS Disorders published a case report on the use of antioxidants in the treatment of tardive dyskinesia. While new pharmacologic discoveries have occurred in the area of movement disorders, their use comes with a large price tag. Thus, for mild cases, clinicians may want to seek out more cost-effective options. Antioxidants may serve a role in the prevention and treatment of tardive dyskinesia due to the oxidative stress hypothesis.This case report describes a man in his 30s with a diagnosis of schizoaffective disorder–bipolar type who began exhibiting involuntary movements of the tongue, lips, and truncal area. While initial agents did not completely improve involuntary movements, combining them with antioxidants such as omega-3/DHA/EPA/DPA, vitamin B6, and melatonin lowered symptom severity. Thus, alternative treatment options may be considered before use of more expensive agents for mild cases of tardive dyskinesia.
Access the entire case report, “Antioxidants for the Treatment of Tardive Dyskinesia: AIMing to Find the Best Treatment Option,” by O. Greg Deardorff, PharmD, BCPP; Kimberly A. Ehrhard, PharmD; Jason Cafer, MD; and Beth M. Hall, PharmD, BCPP, at https://doi.org/10.4088/PCC.18l02375.
The Primary Care Companion for CNS Disorders (PCC) is an international, peer-reviewed, online-only journal, published by Physicians Postgraduate Press, Inc. Its mission is to advance the clinical expertise of primary care physicians and other health care professionals who treat patients with mental and neurologic illnesses. PCC is indexed by the National Library of Medicine.
Sallie Gatlin
Physicians Postgraduate Press
PO Box 752870
Memphis, Tennessee 38175-2870
(901) 273-2753
PrimaryCare@psychiatrist.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antioxidants May Aid in the Treatment of Tardive Dyskinesia here
News-ID: 1733703 • Views: …
More Releases from Physicians Postgraduate Press
New Detailed Review of Oral Ketamine for Depression Published in JCP
Memphis, TN (April 16, 2019) – A review article published today in The Journal of Clinical Psychiatry indicates that orally administered ketamine is efficacious for depression but may take longer to yield results. The review, authored by Joshua D. Rosenblat and colleagues at the University of Toronto, analyzed 13 articles, including 2 randomized controlled trials (RCTs).
The RCTs demonstrated antidepressant efficacy and good tolerability for oral ketamine, but significant changes…
Immigrants at Lower Risk of Substance Use, Psychiatric Disorders Than US-Born Co …
Memphis, TN (February 28, 2019) – Today The Primary Care Companion for CNS Disorders published a study comparing prevalence rates of alcohol, nicotine, and other drug use and major psychiatric disorders between US-born and foreign-born Mexican Americans and non-Hispanic whites.
Hispanics are the leading ethnic majority in the US, and Mexican Americans constitute 60% of the US Hispanic population. Therefore, focus on this group is timely and important, especially since…
More Releases for Primary
Direct Primary Care Market
Direct Primary Care Market Worth 80.4 Bn 2031- Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Direct Primary Care Market"- By Type (Clinical Services, Telehealth Services, Laboratory Services, Consultative Services), Care Setting (Office-Based DPC Practices, Home-Based DPC Practices, Telehealth-Only DPC Practices, Hybrid DPC Practices), End Users (Individuals, Employers, Small Businesses, Large Corporations, Insurance Companies (offering DPC as…
Primary Sclerosing Cholangitis Market
Primary Sclerosing Cholangitis (PSC) is a rare, chronic liver disease characterized by inflammation and scarring of the bile ducts, leading to liver damage and, ultimately, liver failure. The disease progresses slowly and often goes unnoticed in its early stages. Although the exact cause of PSC remains unknown, it is commonly associated with other inflammatory bowel diseases, particularly ulcerative colitis. The management of PSC includes symptom control, slowing disease progression, and…
Primary Biliary Cholangitis Treatment Market
Primary Biliary Cholangitis Treatment Market
Global Primary Biliary Cholangitis Treatment Market Expected to Reach US$ YY Million by 2030, Growing at a CAGR of YY%: Market Insights and Dynamics
The Global Primary Biliary Cholangitis Treatment Market, which reached US$ YY billion in 2022, is anticipated to achieve US$ YY million by 2030, exhibiting a robust CAGR of YY% during the forecast period from 2024 to 2031.
Primary Biliary Cholangitis (PBC), formerly known as…
Primary Healthcare Conference 2023
3rd World Congress on Primary Healthcare and Medicare Summit
Mercure Roma West, Viale degli Eroi di Cefalonia, 301, 00128 Rome, Italy
Email primaryhealthcare@pulsusgathering.org
On behalf of the Conference Organizing Committee, we would like to invite all of you for the "3rd Word Congress on Primary Healthcare and Medicare", which is going to be held in Rome, Italy on September 21-23, 2023. Primary Healthcare 2023 focuses on the basic theme "To Manifest the Multimorbidity…
Primary Lithium Battery (Primary Lithium Batteries) Market Key Companies and Ana …
The global lithium primary batteries market size will grow from $2.83 billion in 2022 to $2.9 billion in 2023 at a compound annual growth rate (CAGR) of 2.5%
Global " Primary Lithium Battery (Primary Lithium Batteries) Market" 2022 Reports give a Key study on the industry status of the Primary Lithium Battery (Primary Lithium Batteries) Manufacturer with the specific statistics, meaning, definition, SWOT Analysis, expert opinion, and recent development across…
Primary Prevention of Cancer
Primary prevention of cancer aims to prevent the disease before it ever occurs. More than 4 in 10 cancers as well as cancer deaths are linked to modifiable risk factors that can be altered as part of primary cancer prevention. The modifiable risk factors for primary prevention include:
1. Cigarette smoking: Smoking causes almost all cases of lung cancer and accounts for 30% of all cancer deaths. Prevention strategy for this risk…
